Shares of Oxford Cannabinoid Technologies Holdings Plc (LON:OCTP – Get Free Report) traded down 4.2% on Thursday . The company traded as low as GBX 0.12 ($0.00) and last traded at GBX 0.12 ($0.00). 11,402,242 shares changed hands during mid-day trading, an increase of 22% from the average session volume of 9,326,041 shares. The stock had previously closed at GBX 0.12 ($0.00).
Oxford Cannabinoid Technologies Price Performance
The stock has a market capitalization of £1.25 million, a PE ratio of -53.10 and a beta of 0.82. The company has a 50 day moving average price of GBX 0.13 and a 200-day moving average price of GBX 0.34.
About Oxford Cannabinoid Technologies
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions.
See Also
- Five stocks we like better than Oxford Cannabinoid Technologies
- Top Stocks Investing in 5G Technology
- Why Call Options Volume for These 2 Stocks Spiked Together
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- MarketBeat Week in Review – 7/22 – 7/26
- How to Choose Top Rated Stocks
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
Receive News & Ratings for Oxford Cannabinoid Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Cannabinoid Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
